Literature DB >> 18424746

Chlamydia muridarum evades growth restriction by the IFN-gamma-inducible host resistance factor Irgb10.

Jörn Coers1, Isaac Bernstein-Hanley, David Grotsky, Iana Parvanova, Jonathan C Howard, Gregory A Taylor, William F Dietrich, Michael N Starnbach.   

Abstract

Chlamydiae are obligate intracellular bacterial pathogens that exhibit a broad range of host tropism. Differences in host tropism between Chlamydia species have been linked to host variations in IFN-gamma-mediated immune responses. In mouse cells, IFN-gamma can effectively restrict growth of the human pathogen Chlamydia trachomatis but fails to control growth of the closely related mouse pathogen Chlamydia muridarum. The ability of mouse cells to resist C. trachomatis replication is largely dependent on the induction of a family of IFN-gamma-inducible GTPases called immunity-related GTPases or IRGs. In this study we demonstrate that C. muridarum can specifically evade IRG-mediated host resistance. It has previously been suggested that C. muridarum inactivates the IRG protein Irga6 (Iigp1) to dampen the murine immune response. However, we show that Irga6 is dispensable for the control of C. trachomatis replication. Instead, an effective IFN-gamma response to C. trachomatis requires the IRG proteins Irgm1 (Lrg47), Irgm3 (Igtp), and Irgb10. Ectopic expression of Irgb10 in the absence of IFN-gamma is sufficient to reduce intracellular growth of C. trachomatis but fails to restrict growth of C. muridarum, indicating that C. muridarum can specifically evade Irgb10-driven host responses. Importantly, we find that Irgb10 protein intimately associates with inclusions harboring C. trachomatis but is absent from inclusions formed by C. muridarum. These data suggest that C. muridarum has evolved a mechanism to escape the murine IFN-gamma response by restricting access of Irgb10 and possibly other IRG proteins to the inclusion.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18424746     DOI: 10.4049/jimmunol.180.9.6237

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  67 in total

1.  Fungal ligands released by innate immune effectors promote inflammasome activation during Aspergillus fumigatus infection.

Authors:  Benoit Briard; Rajendra Karki; R K Subbarao Malireddi; Anannya Bhattacharya; David E Place; Jayadev Mavuluri; Jennifer L Peters; Peter Vogel; Masahiro Yamamoto; Thirumala-Devi Kanneganti
Journal:  Nat Microbiol       Date:  2018-12-03       Impact factor: 17.745

2.  cPLA2 regulates the expression of type I interferons and intracellular immunity to Chlamydia trachomatis.

Authors:  Mark J Vignola; David F Kashatus; Gregory A Taylor; Christopher M Counter; Raphael H Valdivia
Journal:  J Biol Chem       Date:  2010-05-07       Impact factor: 5.157

3.  Ubiquitin systems mark pathogen-containing vacuoles as targets for host defense by guanylate binding proteins.

Authors:  Arun K Haldar; Clémence Foltz; Ryan Finethy; Anthony S Piro; Eric M Feeley; Danielle M Pilla-Moffett; Masaki Komatsu; Eva-Maria Frickel; Jörn Coers
Journal:  Proc Natl Acad Sci U S A       Date:  2015-09-28       Impact factor: 11.205

4.  Chlamydia-specific CD4 T cell clones control Chlamydia muridarum replication in epithelial cells by nitric oxide-dependent and -independent mechanisms.

Authors:  Krupakar Jayarapu; Micah Kerr; Susan Ofner; Raymond M Johnson
Journal:  J Immunol       Date:  2010-10-29       Impact factor: 5.422

5.  Immunity-related GTPase M (IRGM) proteins influence the localization of guanylate-binding protein 2 (GBP2) by modulating macroautophagy.

Authors:  Maria K Traver; Stanley C Henry; Viviana Cantillana; Tim Oliver; Julia P Hunn; Jonathan C Howard; Sandra Beer; Klaus Pfeffer; Jörn Coers; Gregory A Taylor
Journal:  J Biol Chem       Date:  2011-07-12       Impact factor: 5.157

6.  Integrin α4β1 is necessary for CD4+ T cell-mediated protection against genital Chlamydia trachomatis infection.

Authors:  Sergio J Davila; Andrew J Olive; Michael N Starnbach
Journal:  J Immunol       Date:  2014-03-21       Impact factor: 5.422

7.  IRGM3 contributes to immunopathology and is required for differentiation of antigen-specific effector CD8+ T cells in experimental cerebral malaria.

Authors:  Jintao Guo; James A McQuillan; Belinda Yau; Gregory S Tullo; Carole A Long; Patrick Bertolino; Ben Roediger; Wolfgang Weninger; Gregory A Taylor; Nicholas H Hunt; Helen J Ball; Andrew J Mitchell
Journal:  Infect Immun       Date:  2015-02-02       Impact factor: 3.441

8.  T cell responses in the absence of IFN-gamma exacerbate uterine infection with Chlamydia trachomatis.

Authors:  David C Gondek; Nadia R Roan; Michael N Starnbach
Journal:  J Immunol       Date:  2009-06-26       Impact factor: 5.422

9.  IRGB10 Liberates Bacterial Ligands for Sensing by the AIM2 and Caspase-11-NLRP3 Inflammasomes.

Authors:  Si Ming Man; Rajendra Karki; Miwa Sasai; David E Place; Sannula Kesavardhana; Jamshid Temirov; Sharon Frase; Qifan Zhu; R K Subbarao Malireddi; Teneema Kuriakose; Jennifer L Peters; Geoffrey Neale; Scott A Brown; Masahiro Yamamoto; Thirumala-Devi Kanneganti
Journal:  Cell       Date:  2016-09-29       Impact factor: 41.582

10.  Disruption of the Toxoplasma gondii parasitophorous vacuole by IFNgamma-inducible immunity-related GTPases (IRG proteins) triggers necrotic cell death.

Authors:  Yang O Zhao; Aliaksandr Khaminets; Julia P Hunn; Jonathan C Howard
Journal:  PLoS Pathog       Date:  2009-02-06       Impact factor: 6.823

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.